Practical considerations for using functional uniform prior distributions for dose-response estimation in clinical...

Area of Science:

• Biostatistics
• Pharmacometrics
• Clinical Trial Design

Background:

• Estimating nonlinear dose-response relationships in pharmaceutical clinical trials is challenging due to variable and sparse data.
• Maximum likelihood estimates may not exist, and Bayesian methods are sensitive to prior selection without expert elicitation.
• Existing methods struggle with the inherent complexities of dose-response modeling in early-phase trials.

Purpose of the Study:

• To provide guidance on using functional uniform prior distributions for nonlinear dose-response estimation.
• To address the limitations of existing methods in handling data variability and sparsity.
• To offer practical implementation strategies for these priors in clinical trial settings.

Main Methods:

• Utilizing functional uniform priors that equally weight potential shapes of the nonlinear regression function.
• Developing a Bayesian approach that uniformly covers underlying nonlinear function shapes.
• Implementing and illustrating the method in simulated and real-world Phase I and Phase II clinical trial data.

Main Results:

• Functional uniform priors provide a robust approach when maximum likelihood estimates fail.
• The method uniformly covers potential nonlinear function shapes, reducing prior sensitivity issues.
• Practical implementation guidance and examples demonstrate utility in early-phase pharmaceutical trials.

Conclusions:

• Functional uniform priors offer a valuable tool for robust nonlinear dose-response estimation in challenging clinical trial data.
• This approach enhances the reliability of Bayesian inference when dealing with sparse and variable data.
• The proposed methods are applicable to both Phase I (first-in-human) and Phase II dose-response studies.